Pancreatic Cancer Surveillance Programs

 

CGA is pleased to provide a list of programs with experience and expertise in providing pancreatic surveillance for high-risk individuals.

For additional information or questions, please contact CGA at

cga@pacemedcom.com

Approximately 10% of pancreatic cancers are due to a hereditary etiology. Presently only those individuals with a higher lifetime risk of developing a pancreatic adenocarcinoma are candidates for pancreatic cancer surveillance.  Those individuals who are candidates for pancreatic cancer surveillance consists of individuals who have a known hereditary syndrome associated with an increased risk of developing pancreatic cancer or are members of a family with multiple members who have been diagnosed with pancreatic cancer.  Surveillance recommendations are available through the American College of Gastroenterology (ACG) guidelines, National Comprehensive Cancer Network (NCCN) guidelines, and the American Gastroenterology Association (AGA) clinical practice update.  All these guidelines suggest that patients be cared at expert centers that provide a comprehensive multidisciplinary pancreatic cancer surveillance program.  Most of these centers participate in consortiums that encourage the collection of surveillance data in a standardized manner to support research efforts aimed at improving pancreatic cancer surveillance.  CGA members actively participate in the two major international surveillance consortiums: CAPS (International Cancer of the Pancreas Screening) consortium and Pancreatic Cancer Early Detection (PRECEDE) Consortium.

The links below are a global resource of Pancreatic Surveillance Programs.